BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2054456)

  • 1. Niacin test in schizophrenia and affective illness.
    Rybakowski J; Weterle R
    Biol Psychiatry; 1991 Apr; 29(8):834-6. PubMed ID: 2054456
    [No Abstract]   [Full Text] [Related]  

  • 2. Niacin skin flush in schizophrenia: a preliminary report.
    Ward PE; Sutherland J; Glen EM; Glen AI
    Schizophr Res; 1998 Feb; 29(3):269-74. PubMed ID: 9516668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Niacin skin flush test: a research tool for studying schizophrenia.
    Nadalin S; Buretić-Tomljanović A; Rubesa G; Tomljanović D; Gudelj L
    Psychiatr Danub; 2010 Mar; 22(1):14-27. PubMed ID: 20305586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niacin skin flushing in schizophrenic and depressed patients and healthy controls.
    Bosveld-van Haandel L; Knegtering R; Kluiter H; van den Bosch RJ
    Psychiatry Res; 2006 Aug; 143(2-3):303-6. PubMed ID: 16837062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niacin skin flush is not diagnostic of schizophrenia.
    Wilson DW; Douglass AB
    Biol Psychiatry; 1986 Aug; 21(10):974-7. PubMed ID: 3741914
    [No Abstract]   [Full Text] [Related]  

  • 6. Niacin subsensitivity is associated with functional impairment in schizophrenia.
    Messamore E
    Schizophr Res; 2012 May; 137(1-3):180-4. PubMed ID: 22445461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls.
    Nilsson BM; Hultman CM; Wiesel FA
    Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):339-46. PubMed ID: 16600583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane fatty acids, niacin flushing and clinical parameters.
    Glen AI; Cooper SJ; Rybakowski J; Vaddadi K; Brayshaw N; Horrobin DF
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):9-15. PubMed ID: 8888117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The niacin skin flush test in schizophrenia: a replication study.
    Puri BK; Easton T; Das I; Kidane L; Richardson AJ
    Int J Clin Pract; 2001; 55(6):368-70. PubMed ID: 11501224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study.
    Messamore E; Hoffman WF; Janowsky A
    Schizophr Res; 2003 Aug; 62(3):251-8. PubMed ID: 12837522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmedicated schizophrenic patients have a reduced skin flush in response to topical niacin.
    Shah SH; Vankar GK; Peet M; Ramchand CN
    Schizophr Res; 2000 Jun; 43(2-3):163-4. PubMed ID: 11001591
    [No Abstract]   [Full Text] [Related]  

  • 12. Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia.
    Smesny S; Klemm S; Stockebrand M; Grunwald S; Gerhard UJ; Rosburg T; Sauer H; Blanz B
    Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):79-85. PubMed ID: 17904833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absent response to niacin skin patch is specific to schizophrenia and independent of smoking.
    Liu CM; Chang SS; Liao SC; Hwang TJ; Shieh MH; Liu SK; Chen WJ; Hwu HG
    Psychiatry Res; 2007 Aug; 152(2-3):181-7. PubMed ID: 17459487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test-retest stability of the oral niacin test and electrodermal activity in patients with schizophrenia.
    Nilsson BM; Hultman CM; Ekselius L
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):367-72. PubMed ID: 19864122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia?
    Hudson CJ; Lin A; Cogan S; Cashman F; Warsh JJ
    Biol Psychiatry; 1997 Mar; 41(5):507-13. PubMed ID: 9046982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The niacin challenge test in schizophrenia: past, present and future.
    Lin A; Hudson CJ
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):17-9. PubMed ID: 8888118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Niacin sensitivity and the arachidonic acid pathway in schizophrenia.
    Messamore E; Hoffman WF; Yao JK
    Schizophr Res; 2010 Sep; 122(1-3):248-56. PubMed ID: 20417059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case reports: new onset flushing due to unauthorized substitution of niacin for nicotinamide.
    Kademian M; Bechtel M; Zirwas M
    J Drugs Dermatol; 2007 Dec; 6(12):1220-1. PubMed ID: 18189062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in PLA2G6 and PLA2G4C genes for calcium-independent phospholipase A2 do not contribute to attenuated niacin skin flush response in schizophrenia patients.
    Nadalin S; Radović I; Buretić-Tomljanović A
    Prostaglandins Leukot Essent Fatty Acids; 2015 Sep; 100():29-32. PubMed ID: 26160611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New alcohol flushing in a patient with atopic dermatitis under therapy with dupilumab.
    Herz S; Petri M; Sondermann W
    Dermatol Ther; 2019 Jan; 32(1):e12762. PubMed ID: 30288874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.